메뉴 건너뛰기




Volumn 55, Issue 6, 2014, Pages 893-900

The long-term effect of vagus nerve stimulation on quality of life in patients with pharmacoresistant focal epilepsy: The PuLsE (Open Prospective Randomized Long-term Effectiveness) trial

(16)  Ryvlin, Philippe a   Gilliam, Frank G b   Nguyen, Dang K c   Colicchio, Gabriella d   Iudice, Alfonso e   Tinuper, Paolo f   Zamponi, Nelia g   Aguglia, Umberto h   Wagner, Louis i   Minotti, Lorella j   Stefan, Hermann k   Boon, Paul l   Sadler, Mark m   Benna, Paolo n   Raman, Pradheep o   Perucca, Emilio p  


Author keywords

Epilepsy; Health related quality of life; QOLIE 89; Seizures; Vagus nerve stimulation

Indexed keywords

ANTICONVULSIVE AGENT;

EID: 84902360569     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/epi.12611     Document Type: Article
Times cited : (146)

References (22)
  • 1
    • 78651233852 scopus 로고    scopus 로고
    • Vagus nerve stimulation in 436 consecutive patients with treatment-resistant epilepsy: Long-term outcomes and predictors of response
    • Elliott RE, Morsi A, Kalhorn SP, et al. Vagus nerve stimulation in 436 consecutive patients with treatment-resistant epilepsy: long-term outcomes and predictors of response. Epilepsy Behav 2011; 20: 57-63.
    • (2011) Epilepsy Behav , vol.20 , pp. 57-63
    • Elliott, R.E.1    Morsi, A.2    Kalhorn, S.P.3
  • 2
    • 72049122652 scopus 로고    scopus 로고
    • Definition of refractory epilepsy: Defining the indefinable?
    • Kwan P, Brodie MJ,. Definition of refractory epilepsy: defining the indefinable? Lancet Neurol 2010; 9: 27-29.
    • (2010) Lancet Neurol , vol.9 , pp. 27-29
    • Kwan, P.1    Brodie, M.J.2
  • 4
    • 79952735820 scopus 로고    scopus 로고
    • Efficacy of vagus nerve stimulation over time: Review of 65 consecutive patients with treatment-resistant epilepsy treated with VNS > 10 years
    • Elliott RE, Morsi A, Tanweer O, et al. Efficacy of vagus nerve stimulation over time: review of 65 consecutive patients with treatment-resistant epilepsy treated with VNS > 10 years. Epilepsy Behav 2011; 20: 478-483.
    • (2011) Epilepsy Behav , vol.20 , pp. 478-483
    • Elliott, R.E.1    Morsi, A.2    Tanweer, O.3
  • 5
    • 84857830134 scopus 로고    scopus 로고
    • Vagus nerve stimulation: Effectiveness and tolerability in 64 paediatric patients with refractory epilepsies
    • Cersosimo RO, Bartuluchi M, Fortini S, et al. Vagus nerve stimulation: effectiveness and tolerability in 64 paediatric patients with refractory epilepsies. Epileptic Disord 2011; 13: 382-388.
    • (2011) Epileptic Disord , vol.13 , pp. 382-388
    • Cersosimo, R.O.1    Bartuluchi, M.2    Fortini, S.3
  • 6
    • 65549164372 scopus 로고    scopus 로고
    • Vagus nerve stimulation for refractory epilepsy in children: More to VNS than seizure frequency reduction
    • Shahwan A, Bailey C, Maxiner W, et al. Vagus nerve stimulation for refractory epilepsy in children: more to VNS than seizure frequency reduction. Epilepsia 2009; 50: 1220-1228.
    • (2009) Epilepsia , vol.50 , pp. 1220-1228
    • Shahwan, A.1    Bailey, C.2    Maxiner, W.3
  • 7
    • 0037167547 scopus 로고    scopus 로고
    • Earlier use of adjunctive vagus nerve stimulation therapy for refractory epilepsy
    • Renfroe JB, Wheless JW,. Earlier use of adjunctive vagus nerve stimulation therapy for refractory epilepsy. Neurology 2002; 59: S26-S30.
    • (2002) Neurology , vol.59
    • Renfroe, J.B.1    Wheless, J.W.2
  • 8
    • 77958123899 scopus 로고    scopus 로고
    • Chronic intermittent vagal nerve stimulation in the treatment of refractory epilepsy: Experience in Mexico with 35 cases
    • , 24
    • Alonso-Vanegas MA, Austria-Velásquez J, Lõpez-Gõmez M, et al. Chronic intermittent vagal nerve stimulation in the treatment of refractory epilepsy: experience in Mexico with 35 cases. Cir Cir 2010; 78: 15-23, 24.
    • (2010) Cir Cir , vol.78 , pp. 15-23
    • Alonso-Vanegas, M.A.1    Austria-Velásquez, J.2    Lõpez-Gõmez, M.3
  • 9
    • 79955553731 scopus 로고    scopus 로고
    • Vagus nerve stimulation: Effectiveness and tolerability in patients with epileptic encephalopathies
    • Cersosimo RO, Bartuluchi M, De Los Santos C, et al. Vagus nerve stimulation: effectiveness and tolerability in patients with epileptic encephalopathies. Childs Nerv Syst 2011; 27: 787-792.
    • (2011) Childs Nerv Syst , vol.27 , pp. 787-792
    • Cersosimo, R.O.1    Bartuluchi, M.2    De Los Santos, C.3
  • 10
    • 84859436348 scopus 로고    scopus 로고
    • Vagus nerve stimulation has a positive effect on mood in patients with refractory epilepsy
    • Klinkenberg S, Majoie HJ, van der Heijden MM, et al. Vagus nerve stimulation has a positive effect on mood in patients with refractory epilepsy. Clin Neurol Neurosurg 2012; 114: 336-340.
    • (2012) Clin Neurol Neurosurg , vol.114 , pp. 336-340
    • Klinkenberg, S.1    Majoie, H.J.2    Van Der Heijden, M.M.3
  • 11
    • 0028832231 scopus 로고
    • Development of the quality of life in epilepsy inventory
    • Devinsky O, Vickrey BG, Cramer J, et al. Development of the quality of life in epilepsy inventory. Epilepsia 1995; 36: 1089-1104.
    • (1995) Epilepsia , vol.36 , pp. 1089-1104
    • Devinsky, O.1    Vickrey, B.G.2    Cramer, J.3
  • 12
    • 84965520932 scopus 로고
    • The CES-D Scale. A self-report depression scale for research in the general population
    • Radloff LS,. The CES-D Scale. A self-report depression scale for research in the general population. Appl Psychol Meas 1977; 1: 385-401.
    • (1977) Appl Psychol Meas , vol.1 , pp. 385-401
    • Radloff, L.S.1
  • 13
    • 33646067133 scopus 로고    scopus 로고
    • Rapid detection of major depression in epilepsy: A multicentre study
    • Gilliam FG, Barry JJ, Hermann BP, et al. Rapid detection of major depression in epilepsy: a multicentre study. Lancet Neurol 2006; 5: 399-405.
    • (2006) Lancet Neurol , vol.5 , pp. 399-405
    • Gilliam, F.G.1    Barry, J.J.2    Hermann, B.P.3
  • 15
    • 0345975882 scopus 로고    scopus 로고
    • Systematic screening allows reduction of adverse antiepileptic drug effects: A randomized trial
    • Gilliam FG, Fessler AJ, Baker G, et al. Systematic screening allows reduction of adverse antiepileptic drug effects: a randomized trial. Neurology 2004; 62: 23-27.
    • (2004) Neurology , vol.62 , pp. 23-27
    • Gilliam, F.G.1    Fessler, A.J.2    Baker, G.3
  • 16
    • 78751607826 scopus 로고    scopus 로고
    • Adverse antiepileptic drug effects in new-onset seizures: A case-control study
    • Perucca P, Jacoby A, Marson AG, et al. Adverse antiepileptic drug effects in new-onset seizures: a case-control study. Neurology 2011; 76: 273-279.
    • (2011) Neurology , vol.76 , pp. 273-279
    • Perucca, P.1    Jacoby, A.2    Marson, A.G.3
  • 17
    • 77951561572 scopus 로고    scopus 로고
    • Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy
    • Canevini MP, De Sarro G, Galimberti CA, et al. Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy. Epilepsia 2010; 51: 797-804.
    • (2010) Epilepsia , vol.51 , pp. 797-804
    • Canevini, M.P.1    De Sarro, G.2    Galimberti, C.A.3
  • 18
    • 33744461818 scopus 로고    scopus 로고
    • Validity and responsiveness of generic preference-based HRQOL instruments in chronic epilepsy
    • Langfitt JT, Vickrey BG, McDermott MP, et al. Validity and responsiveness of generic preference-based HRQOL instruments in chronic epilepsy. Qual Life Res 2006; 15: 899-914.
    • (2006) Qual Life Res , vol.15 , pp. 899-914
    • Langfitt, J.T.1    Vickrey, B.G.2    McDermott, M.P.3
  • 19
    • 82955207124 scopus 로고    scopus 로고
    • Determinants of health-related quality of life in pharmacoresistant epilepsy: Results from a large multicenter study of consecutively enrolled patients using validated quantitative assessments
    • Luoni C, Bisulli F, Canevini MP, et al. Determinants of health-related quality of life in pharmacoresistant epilepsy: results from a large multicenter study of consecutively enrolled patients using validated quantitative assessments. Epilepsia 2011; 52: 2181-2191.
    • (2011) Epilepsia , vol.52 , pp. 2181-2191
    • Luoni, C.1    Bisulli, F.2    Canevini, M.P.3
  • 20
    • 0036091174 scopus 로고    scopus 로고
    • Seizure reduction and quality of life improvements in people with epilepsy
    • Birbeck GL, Hays RD, Cui X, et al. Seizure reduction and quality of life improvements in people with epilepsy. Epilepsia 2002; 43: 535-538.
    • (2002) Epilepsia , vol.43 , pp. 535-538
    • Birbeck, G.L.1    Hays, R.D.2    Cui, X.3
  • 21
    • 0037631878 scopus 로고    scopus 로고
    • Quality of life after vagus nerve stimulation for intractable epilepsy: Is seizure control the only contributing factor?
    • McLachlan RS, Sadler M, Pillay N, et al. Quality of life after vagus nerve stimulation for intractable epilepsy: is seizure control the only contributing factor? Eur Neurol 2003; 50: 16-19.
    • (2003) Eur Neurol , vol.50 , pp. 16-19
    • McLachlan, R.S.1    Sadler, M.2    Pillay, N.3
  • 22
    • 0033544431 scopus 로고    scopus 로고
    • Long-term treatment with vagus nerve stimulation in patients with refractory epilepsy. The Vagus Nerve Stimulation Study Group E01-E05
    • Morris GL 3rd, Mueller WM,. Long-term treatment with vagus nerve stimulation in patients with refractory epilepsy. The Vagus Nerve Stimulation Study Group E01-E05. Neurology 1999; 53: 1731-1735.
    • (1999) Neurology , vol.53 , pp. 1731-1735
    • Morris III, G.L.1    Mueller, W.M.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.